MedPath

Required propofol dose and time to emerge for anesthesia, affect by antiepileptics and disability

Not Applicable
Conditions
patients with neurological disorder who were treated under intravenous general anesthesia
Registration Number
JPRN-UMIN000012882
Lead Sponsor
Kagoshima university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

The cases that did not use TCI and BIS or did not consent of study were excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We measure predictive blood concentration, time for emergence and propofol dose.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath